Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × fluoromisonidazole × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Glioblastoma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage III Lung Non-Small Cell Cancer AJCC v7 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma 1 Melanoma 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 55 Bevacizumab 51 Radiotherapy 34 Radiosurgery 24 Carboplatin 20 pembrolizumab 15 Irinotecan 14 Etoposide 14 Nivolumab 13 Cisplatin 13 Carmustine 13 Cyclophosphamide 12 Pemetrexed 11 Ipilimumab 11 Erlotinib Hydrochloride 11 Magnetic Resonance Spectroscopy 10 Surgical Procedures, Operative 9 Lapatinib 9 Capecitabine 9 Topotecan 8 Thalidomide 8 Aminolevulinic Acid 8 Lomustine 7 Gefitinib 7 Filgrastim 7 trametinib 6 osimertinib 6 encorafenib 6 binimetinib 6 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01868906 2018-08-24

FMISOPETSCS

Dr. Negrin University Hospital

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡